INC

Quintiles, Sinclair ink 10-year partnership to commercialize portfolio in Mexico

Wednesday, September 19, 2012 11:37 AM

Quintiles, a fully integrated biopharmaceutical services company, and Sinclair IS Pharma, a topicals and supportive care specialist, have signed a 10-year collaboration and licensing agreement for Quintiles (Rowfarma Mexico) to commercialize Sinclair’s portfolio of dermo-cosmetic products and medical devices in Mexico.

More... »

INC Research expands in South Korea

Monday, September 17, 2012 09:27 AM

INC Research, a therapeutically focused CRO based in Raleigh, N.C., has opened a facility in Seoul, South Korea to manage the growing demand for world-class clinical development programs.

More... »

INC Research wins IACET accreditation for corporate training

Tuesday, August 28, 2012 12:26 PM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO, has been accredited as an authorized provider of the International Association of Continuing Education and Training (IACET), strengthening its corporate training programs. INC says it is the only global CRO authorized provider offering Continuing Education Units (CEUs) that qualify under the ANSI/IACET standard.

More... »

INC Research promotes Macdonald to CEO, Ogle to continue as chairman

Friday, August 17, 2012 07:42 AM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO has, as part of a planned succession, promoted Chief Operating Officer Jamie Macdonald to president and Chief Executive Officer. Chairman and CEO James T. Ogle will continue to serve as chairman.

More... »

Icon appoints three to senior clinical and laboratory positions

Tuesday, July 3, 2012 10:49 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has appointed three additions to the senior management teams of its clinical and central laboratories businesses.

More... »

Horizon and Mallinckrodt to co-promote Duexis

Monday, June 18, 2012 09:54 AM

Mallinckrodt, the pharmaceuticals business of Covidien, has entered into a co-promotion agreement with Horizon Pharma of Deerfield, Ill., to promote the latter’s proprietary drug Duexis, a single-tablet combination of ibuprofen and the histamine H2-receptor antagonist famotidine for symptom relief of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers.

More... »

Trial Masters and Zeincro merge to create specialist CRO in South-Eastern Europe

Thursday, June 14, 2012 10:00 AM

Zeincro, a specialist provider of clinical research services in Greece, Turkey and Cyprus, is merging with Trial Masters, a CRO managing clinical trials in Hungary and Romania.

More... »

INC Research selects TransPerfect’s Trial Interactive as eTMF solution

Thursday, May 17, 2012 09:18 AM

INC Research, a therapeutically focused CRO, has selected Trial Interactive as its global electronic Trial Master File (eTMF) solution, according to TransPerfect, a provider of e-clinical technologies and creator of Trial Interactive. Trial Interactive is a secure, web-based platform that reduces the redundancies inherent in paper-based TMF management.

More... »

INC Research expands partnership with Medidata Solutions

Friday, May 11, 2012 11:32 AM

INC Research, a therapy-focused CRO, has broadened its services around Medidata Solutions' clinical cloud platform by attaining three new accreditations.

More... »

Report: INC Research to close clinical unit in W. Virginia

Thursday, April 26, 2012 03:01 PM

INC Research of Raleigh, N.C., confirmed it is closing its clinical study unit in Morgantown, W.V., according to an online report in The State Journal.

More... »